Are Wall Street Analysts Predicting IQVIA Holdings Stock Will Climb or Sink?

With a market cap of $28.6 billion, IQVIA Holdings Inc. (IQV) is a global provider of clinical research services, healthcare analytics, and commercial intelligence solutions for the life sciences and healthcare industries. The company operates through three business segments: Technology & Analytics Solutions; Research & Development Solutions; and Contract Sales & Medical Solutions, offering data-driven insights, clinical trial support, and healthcare engagement services to pharmaceutical, biotechnology, and medical device companies worldwide.

Shares of IQVIA Holdings have lagged behind the broader market over the past 52 weeks. IQVIA stock has increased 22.4% over this time frame, while the broader S&P 500 Index ($SPX) has gained 26.9%. In addition, the stock has declined 25.4% on a YTD basis, compared to SPX's 8.3% gain.